The STRIDENT Studies

Improving Crohn’s Disease Treatment

 

The STRIDENT studies aim to improve treatment of the commonest complication of Crohn's disease: narrowing of the bowel (strictures). These bowel complications often necessitate surgery to remove the affected bowel. This research programme aims to demonstrate that intense non-surgical therapy can heal the bowel.

Most patients with Crohn’s disease at some stage develop complications of the disease and require an operation. The most common complication is bowel narrowing.

 

The STRIDENT studies aim to heal the bowel using intense treatment, or stretch narrowing more effectively, to prevent the need for an operation.

The STRIDENT (Stricture Definition and Treatment) studies focus on treating Crohn’s disease complications more effectively. They examine how intense drug treatment can heal the bowel, preventing the need for surgery.  They also research more effective ways to safely stretch the bowel, relieving obstruction.    

These are the first studies of this type in the world to address this particular Crohn’s disease complication.

 

An expert team of researchers at St VIncent’s Hospital, in collaboration with researchers at other Melbourne university hospitals, will manage patients over the next four years.

The STRIDENT Studies: Solving the commonest and most neglected complication of Inflammatory Bowel Disease

PROFESSOR MICHAEL KAMM
PROFESSOR OF

GASTROENTEROLOGY
University of Melbourne,

St Vincent’s Hospital
and Imperial College London

DR. EMILY WRIGHT

GASTROENTEROLOGIST

University of Melbourne,

DR. BRONTE HOLT
GASTROENTEROLOGIST
St Vincent’s Hospital, Melbourne
 

DR. JULIEN SCHULBERG
GASTROENTEROLOGIST
University of Melbourne,

and St. Vincent's Hsopital

ALYSON ROSS

RESEARCH NURSE SPECIALIST

St. Vincent's Hospital

DR. AMY HAMILTON

CLINICAL SCIENTIST

University of Melbourne,

St Vincent’s Hospital
 

© 2017 by AGIRF 

  • Instagram - Grey Circle
  • Facebook Clean Grey
  • Twitter Clean Grey